- Home
- Publications
- Publication Search
- Publication Details
Title
Drug resistance in cancer: mechanisms and tackling strategies
Authors
Keywords
-
Journal
Pharmacological Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-23
DOI
10.1007/s43440-020-00138-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of mitomycin C on X-ray repair cross complementing group 1 expression and consequent cytotoxicity regulation in human gastric cancer cells
- (2019) Shui-Yi Tung et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The role and mechanisms of action of microRNAs in cancer drug resistance
- (2019) Wengong Si et al. Clinical Epigenetics
- Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures
- (2019) Dirk Schumacher et al. PLoS Genetics
- Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance
- (2019) Meng Lei et al. DRUG DELIVERY
- TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response
- (2019) Chiao-En Wu et al. Cancer Cell International
- Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway
- (2019) Ligong Chang et al. Lipids in Health and Disease
- Molecular determinants as therapeutic targets in cancer chemotherapy: An update
- (2019) Tanweer Haider et al. PHARMACOLOGY & THERAPEUTICS
- Chemoresistance in gastric cancer is attributed to the overexpression of excision repair cross‐complementing 1 (ERCC1) caused by microRNA‐122 dysregulation
- (2019) Ai‐Ling Song et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SREBP1-dependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait
- (2019) Su Wu et al. Scientific Reports
- The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma
- (2019) Sze Wai Fung et al. CANCER LETTERS
- Silencing of LncRNA-HOTAIR decreases drug resistance of Non-Small Cell Lung Cancer cells by inactivating autophagy via suppressing the phosphorylation of ULK1
- (2018) Yan Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis
- (2018) Zhe Han et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions
- (2018) Xingyan Ju et al. BIOMEDICINE & PHARMACOTHERAPY
- Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma
- (2018) Timothy Budden et al. BMC CANCER
- The UDP-glucose ceramide glycosyltransferase (UGCG) and the link to multidrug resistance protein 1 (MDR1)
- (2018) Marthe-Susanna Wegner et al. BMC CANCER
- Novel Quinoxaline-2-Carbonitrile-1,4-Dioxide Derivatives Suppress HIF1α Activity and Circumvent MDR in Cancer Cells
- (2018) Alexander M. Scherbakov et al. CANCER INVESTIGATION
- Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer
- (2018) Santosh Kumar Singh et al. CANCER LETTERS
- UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells
- (2018) Marthe-Susanna Wegner et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Eukaryotic initiation factor 4F — sidestepping resistance mechanisms arising from expression heterogeneity
- (2018) Jennifer Chu et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells
- (2018) Lang He et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Loss of EGFR confers acquired resistance to AZD9291 in an EGFR-mutant non-small cell lung cancer cell line with an epithelial–mesenchymal transition phenotype
- (2018) Jing Xu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Effect of 5-fluorouracil on excision repair cross-complementing 1 expression and consequent cytotoxicity regulation in human gastric cancer cells
- (2018) Jing-Lan Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hyaluronated Imatinib Liposomes with Hybrid approach to Target CD44 and P-gp Overexpressing MDR Cancer: An In-vitro, In-vivo and Mechanistic Investigation
- (2018) Lalit Mohan Negi et al. JOURNAL OF DRUG TARGETING
- Therapeutically targeting tumor microenvironment–mediated drug resistance in estrogen receptor–positive breast cancer
- (2018) Kevin Shee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway
- (2018) Tianxiao Gong et al. Journal of Translational Medicine
- Omega-3 fatty acids, membrane remodeling and cancer prevention
- (2018) Natividad R. Fuentes et al. MOLECULAR ASPECTS OF MEDICINE
- Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors
- (2018) Julia Boshuizen et al. NATURE MEDICINE
- Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
- (2018) Jente van Staalduinen et al. ONCOGENE
- Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer
- (2018) Özge Saatci et al. ONCOGENE
- Interacting Cancer Machineries: Cell Signaling, Lipid Metabolism, and Epigenetics
- (2018) Thomas W. Grunt TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
- (2018) Hai Wang et al. Nature Communications
- Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response
- (2018) Xiaobin Zheng et al. Oncotarget
- Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines
- (2018) Eric Kübler et al. Oncotarget
- Targeting a Sirt5-Positive Subpopulation Overcomes Multidrug Resistance in Wild-Type Kras Colorectal Carcinomas
- (2018) ZunGuo Du et al. Cell Reports
- Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells
- (2018) Wan-angkan Poolsri et al. Biomed Research International
- Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma
- (2018) Wing Yin Tong et al. JOURNAL OF NANOBIOTECHNOLOGY
- Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways
- (2018) Chao-Yue Sun et al. Frontiers in Pharmacology
- Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
- (2018) Farzana Ahmed et al. Frontiers in Oncology
- Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
- (2018) Jens C. Hahne et al. Frontiers in Oncology
- Simultaneous Fluorescence Visualization of Epithelial–Mesenchymal Transition and Apoptosis Processes in Tumor Cells for Evaluating the Impact of Epithelial–Mesenchymal Transition on Drug Efficacy
- (2018) Mingming Luan et al. ANALYTICAL CHEMISTRY
- Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression
- (2018) Ulises Daniel Orlando et al. BIOCHEMICAL PHARMACOLOGY
- Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance
- (2018) Monish Ram Makena et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- State-of-art based approaches for anticancer drug-targeting to nucleus
- (2018) Rahul Tiwari et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- CSIG-32. DUAL PI3K/Akt INHIBITION TO OVERCOME THE P-gp/BCRP DRUG EFFLUX SYSTEM FOR IMPROVED DRUG DELIVERY IN GLIOBLASTOMA THERAPY
- (2018) Anika Hartz et al. NEURO-ONCOLOGY
- Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
- (2018) Ah-Rong Nam et al. Cancer Research and Treatment
- Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53-Mutated Cells
- (2018) Lukasz Skalniak et al. Cancers
- Integrative PDGF/PDGFR and focal adhesion pathways are downregulated in ERCC1-defective non-small cell lung cancer undergoing sodium glycididazole-sensitized cisplatin treatment
- (2018) Lang He et al. GENE
- Platinum(IV) prodrugs multiply targeting genomic DNA, histone deacetylases and PARP-1
- (2017) Zichen Xu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects
- (2017) Zhiwang Song et al. International Journal of Nanomedicine
- Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles
- (2017) Shoshiro Yamamoto et al. JOURNAL OF CONTROLLED RELEASE
- Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways
- (2017) Jessica Brandi et al. Journal of Proteomics
- Knockdown of long non-coding RNA prostate cancer-associated ncRNA transcript 1 inhibits multidrug resistance and c-Myc-dependent aggressiveness in colorectal cancer Caco-2 and HT-29 cells
- (2017) Lei Qiao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells
- (2017) Cheng Gao et al. Nanoscale
- Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
- (2017) Alvin P Makohon-Moore et al. NATURE GENETICS
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)
- (2017) T Mitamura et al. ONCOGENE
- Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas
- (2017) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Fatty acid synthase – Modern tumor cell biology insights into a classical oncology target
- (2017) Douglas Buckley et al. PHARMACOLOGY & THERAPEUTICS
- Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
- (2017) Rajasekharan Somasundaram et al. Nature Communications
- Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis
- (2017) Richard Jennemann et al. Oncotarget
- Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients
- (2017) Stefanie Avril et al. Oncotarget
- A rapid albumin-binding 5-fluorouracil prodrug with a prolonged circulation time and enhanced antitumor activity
- (2017) Dongyang Zhao et al. Biomaterials Science
- Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
- (2017) T Avril et al. Oncogenesis
- Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology
- (2016) Tim Y. Hou et al. Annual Review of Nutrition
- Mechanisms of Resistance to Chemotherapy in Gastric Cancer
- (2016) J.J.G. Marin et al. Anti-Cancer Agents in Medicinal Chemistry
- Increased expression of LncRNA PANDAR predicts a poor prognosis in gastric cancer
- (2016) Pei Ma et al. BIOMEDICINE & PHARMACOTHERAPY
- Tumor microenvironment and cancer therapy resistance
- (2016) Yu Sun CANCER LETTERS
- Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade
- (2016) Alexandra Eichten et al. CANCER RESEARCH
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Essential Role of DNA Methyltransferase 1–mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors
- (2016) Hye-Young Min et al. CLINICAL CANCER RESEARCH
- CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel
- (2016) Eameema Muntimadugu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Role of the tumor stroma in resistance to anti-angiogenic therapy
- (2016) Elisabeth J.M. Huijbers et al. DRUG RESISTANCE UPDATES
- Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor
- (2016) Shintaro Iwasaki et al. NATURE
- Transferrin-conjugated paclitaxel prodrugs for targeted cancer therapy
- (2016) Lingling Shan et al. RSC Advances
- G-protein coupled receptor PAR1 is overexpressed in glioma progenitor cells
- (2016) Rachel Bar-Shavit et al. Translational Cancer Research
- Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance
- (2015) Xian-wen Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The role of exosomes and “exosomal shuttle microRNA” in tumorigenesis and drug resistance
- (2015) Lei Zhao et al. CANCER LETTERS
- DNA damage response – A double-edged sword in cancer prevention and cancer therapy
- (2015) Hui Tian et al. CANCER LETTERS
- miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts
- (2015) Koji Tanaka et al. CARCINOGENESIS
- TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
- (2015) Naoki Oshimori et al. CELL
- Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts
- (2015) K. Kemper et al. EMBO Molecular Medicine
- Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells
- (2015) Andreas Tyler et al. EXPERIMENTAL CELL RESEARCH
- Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1
- (2015) Catia Lippolis et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- Sustained Epigenetic Drug Delivery Depletes Cholesterol–Sphingomyelin Rafts from Resistant Breast Cancer Cells, Influencing Biophysical Characteristics of Membrane Lipids
- (2015) Vijay Raghavan et al. LANGMUIR
- Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2
- (2015) B. D. Smith et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the translation machinery in cancer
- (2015) Mamatha Bhat et al. NATURE REVIEWS DRUG DISCOVERY
- Broad targeting of resistance to apoptosis in cancer
- (2015) Ramzi M. Mohammad et al. SEMINARS IN CANCER BIOLOGY
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer
- (2015) Xiaohong Xie et al. TUMOR BIOLOGY
- Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric Cancer
- (2015) E. L. Kwak et al. Cancer Discovery
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition
- (2015) Catherine Wilson et al. Oncotarget
- ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
- (2014) Young Choi et al. CURRENT PHARMACEUTICAL DESIGN
- Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma
- (2014) Divya Bansal et al. DRUG DELIVERY
- Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma
- (2014) Vikas Pandey et al. DRUG DELIVERY
- Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells
- (2014) Daniel Veigel et al. INTERNATIONAL JOURNAL OF CANCER
- PJ34, a poly(ADP-ribose) polymerase (PARP) inhibitor, reverses melphalan-resistance and inhibits repair of DNA double-strand breaks by targeting the FA/BRCA pathway in multidrug resistant multiple myeloma cell line RPMI8226/R
- (2014) TING XIONG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Silencing of Long Noncoding RNA MALAT1 by miR-101 and miR-217 Inhibits Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma Cells
- (2014) Xinyu Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
- (2014) Xun Yuan et al. Journal of Hematology & Oncology
- Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug–Drug Conjugate for Cancer Therapy
- (2014) Ping Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Establishment and biological characteristics of acquired gefitinib resistance in cell line NCI-H1975/gefinitib-resistant with epidermal growth factor receptor T790M mutation
- (2014) BAO-XIA ZHAO et al. Molecular Medicine Reports
- Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
- (2014) Yu-Li Lo et al. PLoS One
- Targeting EMT in cancer: opportunities for pharmacological intervention
- (2014) Felicity M. Davis et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway
- (2014) Ping Chen et al. TUMOR BIOLOGY
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
- (2013) Jose JG Marin et al. ACTA PHARMACOLOGICA SINICA
- Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles
- (2013) Qin Liu et al. BIOMATERIALS
- Sunitinib Reverse Multidrug Resistance in Gastric Cancer Cells by Modulating Stat3 and Inhibiting P-gp Function
- (2013) Ye Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
- (2013) Ziyad Binkhathlan et al. CURRENT CANCER DRUG TARGETS
- Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production
- (2013) Hailan Liu et al. JOURNAL OF LIPID RESEARCH
- Paclitaxel-loaded nanoparticles decorated with anti-CD133 antibody: a targeted therapy for liver cancer stem cells
- (2013) Cheng Jin et al. JOURNAL OF NANOPARTICLE RESEARCH
- Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer
- (2013) Xiaosong Ge et al. MEDICAL ONCOLOGY
- P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387
- (2013) S. Durmus et al. PHARMACOLOGICAL RESEARCH
- Use of a Glycolipid Inhibitor to Ameliorate Renal Cancer in a Mouse Model
- (2013) Subroto Chatterjee et al. PLoS One
- Epigenetic Modulation of the Biophysical Properties of Drug-Resistant Cell Lipids to Restore Drug Transport and Endocytic Functions
- (2012) Sivakumar Vijayaraghavalu et al. MOLECULAR PHARMACEUTICS
- Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
- (2012) Fariz Nurwidya et al. Cancer Research and Treatment
- Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology
- (2012) Xue Xue et al. Chinese Journal of Cancer
- Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
- (2011) Inthrani R. Indran et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation
- (2011) Jose T. Thaiparambil et al. INTERNATIONAL JOURNAL OF CANCER
- Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
- (2011) Barbara Norquist et al. JOURNAL OF CLINICAL ONCOLOGY
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
- (2011) Jonathan W. Wojtkowiak et al. MOLECULAR PHARMACEUTICS
- A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer
- (2011) A Bonnomet et al. ONCOGENE
- Amplification of the Driving Oncogene, KRAS or BRAF, Underpins Acquired Resistance to MEK1/2 Inhibitors in Colorectal Cancer Cells
- (2011) A. S. Little et al. Science Signaling
- Epigenetic changes of DNA repair genes in cancer
- (2011) C. Lahtz et al. Journal of Molecular Cell Biology
- Poly(l-lactide)-Vitamin E TPGS Nanoparticles Enhanced the Cytotoxicity of Doxorubicin in Drug-Resistant MCF-7 Breast Cancer Cells
- (2010) Po-Yu Li et al. BIOMACROMOLECULES
- miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
- (2010) Wei Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting nanoparticles to cancer
- (2010) M. Wang et al. PHARMACOLOGICAL RESEARCH
- Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma
- (2010) Michiro Susa et al. PLoS One
- MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
- (2010) N. Valeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer
- (2009) A. Sabharwal et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
- (2009) T. Wilson et al. CURRENT CANCER DRUG TARGETS
- T670X KIT Mutations in Gastrointestinal Stromal Tumors: Making Sense of Missense
- (2009) T. Negri et al. JNCI-Journal of the National Cancer Institute
- Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
- (2009) Emily Gullotti et al. MOLECULAR PHARMACEUTICS
- Vandetanib (Zactima, ZD6474) Antagonizes ABCC1- and ABCG2-Mediated Multidrug Resistance by Inhibition of Their Transport Function
- (2009) Li-sheng Zheng et al. PLoS One
- miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
- (2008) Lin Xia et al. INTERNATIONAL JOURNAL OF CANCER
- Low Expression of Bax Predicts Poor Prognosis in Resected Non-small Cell Lung Cancer Patients with Non-squamous Histology
- (2008) S. H. Jeong et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
- (2008) Monika E. Hegi et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started